Cargando…

Depression Symptoms in Haemodialysis Patients Predict All-Cause Mortality but Not Kidney Transplantation: A Cause-Specific Outcome Analysis

BACKGROUND: Depression is common in haemodialysis (HD) patients and associated with poor outcomes. PURPOSE: To evaluate whether depression symptoms predict survival and transplantation in a large sample of haemodialysis patients using cause-specific survival models. METHODS: Survival data was collec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chilcot, Joseph, Guirguis, Ayman, Friedli, Karin, Almond, Michael, Day, Clara, Da Silva-Gane, Maria, Davenport, Andrew, Fineberg, Naomi A, Spencer, Benjamin, Wellsted, David, Farrington, Ken
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6367894/ https://www.ncbi.nlm.nih.gov/pubmed/28762106 http://dx.doi.org/10.1007/s12160-017-9918-9

Ejemplares similares

A study of sertraline in dialysis (ASSertID): a protocol for a pilot randomised controlled trial of drug treatment for depression in patients undergoing haemodialysis
por: Friedli, Karin, et al.
Publicado: (2015)

How do patients from South Asian backgrounds experience life on haemodialysis in the UK? A multicentre qualitative study
por: Sharma, Shivani, et al.
Publicado: (2019)

The use of culturally adapted and translated depression screening questionnaires with South Asian haemodialysis patients in England
por: Sharma, Shivani, et al.
Publicado: (2023)

Self-reported antidepressant use in haemodialysis patients is associated with increased mortality independent of concurrent depression severity
por: Chilcot, Joseph, et al.
Publicado: (2019)

Identifying Depression in South Asian Patients with End-Stage Renal Disease: Considerations for Practice
por: Sharma, Shivani, et al.
Publicado: (2011)

Cognitive-behavioural therapy (CBT) for renal fatigue (BReF): a feasibility randomised-controlled trial of CBT for the management of fatigue in haemodialysis (HD) patients
por: Picariello, Federica, et al.
Publicado: (2018)

Characteristics of Frailty in Haemodialysis Patients
por: Hendra, Heidy, et al.
Publicado: (2022)

Impact of incremental versus conventional initiation of haemodialysis on residual kidney function: study protocol for a multicentre feasibility randomised controlled trial
por: Kaja Kamal, Raja Mohammed, et al.
Publicado: (2020)

Association of Versican Turnover with All-Cause Mortality in Patients on Haemodialysis
por: Genovese, Federica, et al.
Publicado: (2014)

Home haemodialysis: trends in technology
por: Farrington, Ken, et al.
Publicado: (2011)

Associations between dynapenia, cardiovascular hospitalizations, and all‐cause mortality among patients on haemodialysis
por: Yoshikoshi, Shun, et al.
Publicado: (2022)

Haemoglobin variability and all‐cause mortality in haemodialysis patients: A systematic review and meta‐analysis
por: Zhao, Lingfei, et al.
Publicado: (2019)

Causes of Vitamin K Deficiency in Patients on Haemodialysis
por: Wikstrøm, Signe, et al.
Publicado: (2020)

Contributions of treatment centre and patient characteristics to patient-reported experience of haemodialysis: a national cross-sectional study
por: Hawkins, Janine, et al.
Publicado: (2021)

A prospective study of fatigue trajectories among in‐centre haemodialysis patients
por: Picariello, Federica, et al.
Publicado: (2019)

An unusual cause of pleural effusion in a haemodialysis patient
por: Hamming, Inge, et al.
Publicado: (2009)

Superior vena cava syndrome caused by haemodialysis catheter
por: Lee, Shen-Yang, et al.
Publicado: (2010)

Pre-Dialysis Systolic Blood Pressure-Variability Is Independently Associated with All-Cause Mortality in Incident Haemodialysis Patients
por: Selvarajah, Viknesh, et al.
Publicado: (2014)

Paradoxical positive association of serum adiponectin with all-cause mortality based on body composition in Japanese haemodialysis patients
por: Machiba, Yuri, et al.
Publicado: (2018)

Arteriovenous fistula thrombosis is associated with increased all-cause and cardiovascular mortality in haemodialysis patients from the AURORA trial
por: Girerd, Sophie, et al.
Publicado: (2019)

Broadening Options for Long-term Dialysis in the Elderly (BOLDE): differences in quality of life on peritoneal dialysis compared to haemodialysis for older patients
por: Brown, Edwina A., et al.
Publicado: (2010)

Quality of life with conservative care compared with assisted peritoneal dialysis and haemodialysis
por: Iyasere, Osasuyi, et al.
Publicado: (2018)

Change in FGF23 concentration over time and its association with all-cause mortality in patients treated with haemodialysis or haemodiafiltration
por: Bouma-de Krijger, Annet, et al.
Publicado: (2020)

Neurogenic pulmonary oedema post-haemodialysis
por: Davenport, Andrew
Publicado: (2008)

A self-report comorbidity questionnaire for haemodialysis patients
por: Sridharan, Sivakumar, et al.
Publicado: (2014)

Depression and clinical outcomes in CKD: do anti-depressants play a role? (EQUAL study)
por: Chilcot, Joseph, et al.
Publicado: (2022)

The role of natriuretic peptides in volume assessment and mortality prediction in Haemodialysis patients
por: Sivalingam, Murugan, et al.
Publicado: (2015)

Pyrexia of unknown origin in a haemodialysis patient
por: Davenport, A.
Publicado: (2008)

A comparative study of blood endotoxin detection in haemodialysis patients
por: Wong, Jonathan, et al.
Publicado: (2016)

Race, Depressive Symptoms, and All-Cause Mortality in the United States
por: Assari, Shervin, et al.
Publicado: (2016)

Renal Association Clinical Practice Guideline on Haemodialysis
por: Ashby, Damien, et al.
Publicado: (2019)

Patients’ and carers’ experiences of interacting with home haemodialysis technology: implications for quality and safety
por: Rajkomar, Atish, et al.
Publicado: (2014)

Impact of the COVID-19 pandemic on services for patients with chronic kidney disease: findings of a national survey of UK kidney centres
por: Mackintosh, Lucy, et al.
Publicado: (2023)

Adequacy of haemodialysis and or haemofiltration treatments for patients with acute kidney injury
por: Davenport, Andrew
Publicado: (2010)

Oral mucosal lesions and risk of all-cause and cardiovascular mortality in people treated with long-term haemodialysis: The ORAL-D multinational cohort study
por: Ruospo, Marinella, et al.
Publicado: (2019)

Soluble suppression of tumorigenesis-2 is a strong predictor of all-cause, cardiovascular and infection-related mortality risk in haemodialysis patients with diabetes mellitus
por: Hammer, Fabian, et al.
Publicado: (2022)

Predictive role of cardiac valvular calcification in all-cause mortality of Chinese initial haemodialysis patients: a follow-up study of 4 years
por: Cheng, Yun, et al.
Publicado: (2023)

Development of a prediction model to estimate the 5-year risk of cardiovascular events and all-cause mortality in haemodialysis patients: a retrospective study
por: Zhang, Aihong, et al.
Publicado: (2022)

Ascites due to right atrial myxoma in a haemodialysis patient
por: Banerjee, Anindya, et al.
Publicado: (2006)

Depressive Symptoms Associate With Race and All-Cause Mortality in Patients With CKD
por: Tuot, Delphine S., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_s4j605j0le3ac0cvmbsdd6vd48